Vaccine

Vaccine - most related articles:

- Many parents, high priority adults didn't get H1N1 vaccine - 4.3
- Universal Influenza vaccine holds promise - 4.3
- Universal influenza vaccine possible in future - 4.1
- Swine flu vaccine causing sudden sleep disorder narcolepsy in children - 4.1
- New bird flu vaccine may give long-term defense - 3.9
- Sanofi Pasteur's New Influenza Vaccine Plant, US - 3.9
- Swine flu vaccine trials under way, UK - 3.9
- Swine flu vaccine candidate prepared by UK - 3.8
- HPV vaccine's hypersensitivity reactions are rare - 3.7
- Ixiaro to prevent Japanese Encephalitis approved in Europe - 3.7

Vaccine articles

Brain cancer vaccine prepared from brain tumor proves effective
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme-which kills thousands of Americans every year.

HPV vaccine reduces subsequent cervical disease in women
HPV vaccination does not reduce progression to cervical disease in women, but vaccinated women had less frequent subsequent cervical disease. Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease.

Prevnar 13 vaccine approved for people ages 50 and older
Prevnar 13, a pneumonia vaccine, is approved for people ages 50 years and older to prevent pneumonia and invasive disease caused by the bacterium, Streptococcus pneumoniae.

New malaria vaccine may make all strains of malaria parasite ineffective
A new candidate malaria vaccine with the potential to neutralise all strains of the most deadly species of malaria parasite has been developed by a team led by scientists at the University of Oxford, UK.

Breast cancer vaccine reduces tumours in mice
Researchers have developed a vaccine that dramatically reduces tumors in a mouse model that mimics 90 percent of human breast and pancreatic cancer cases-including those that are resistant to common treatments.

US Pediatrics agency updates guidelines on polio vaccination
Despite significant progress in eliminating polio, wild poliovirus persists in a small number of Asian and African countries. It is essential to ensure high levels of immunity in U.S. children to prevent outbreaks in case the virus is imported here.

Developing possibility of a preventive vaccine against HIV AIDS
The HIV epidemic is the largest in the world and represents one of the most serious public health problems, according to data from the World Health Organization (WHO). Only 30% of the more than 10 million patients in need have the access to the antiretroviral treatment.

Swine flu vaccine causing sudden sleep disorder narcolepsy in children
A swine flu vaccine which has been given to thousands of children in Britain may cause the sleep disorder narcolepsy. Symptoms include excessive daytime sleepiness and nodding off suddenly without warning.

Vaccine to prevent meningococcal disease in infants and toddlers
The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.

Gardasil approved to prevent anal cancer
The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.

New cancer research could lead to improved vaccines for cancerous tumors
Researchers at the University of Cambridge hope to revolutionise cancer therapy after discovering one of the reasons why many previous attempts to harness the immune system to treat cancerous tumours have failed.

Antibodies can stop most HIV strains from infecting human cells
Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory, and have demonstrated how one of these disease-fighting proteins accomplishes this feat.

MMRV vaccine linked to double risk of seizures
The combination vaccine for measles, mumps, rubella and chickenpox (MMRV) is associated with double the risk of febrile seizures for 1- to 2-year-old children compared with same-day administration of the separate vaccine for MMR (measles, mumps, rubella) and the varicella (V) vaccine for chicken pox.

Vaccine hope for skin cancer sufferers
Nottingham scientists have been given the green light to test a vaccine which they hope could reverse, and even cure malignant melanoma, the most deadly type of skin cancer.

Universal influenza vaccine possible in future
Researchers at Mount Sinai School of Medicine have developed a new influenza vaccine that brings science one step closer to a universal influenza vaccine that would eliminate the need for seasonal flu shots.

Vaccine to help people quit smoking
In a unique twist to a decades-old health crisis, Michigan State University researchers are testing a new vaccine to help people quit smoking and avoid relapses.

Thimerosal in vaccine cannot cause autism - vaccine court, US
US 'vaccine court' ruled in three separate cases that the mercury containing preservative thiomersal does not cause autism. This ruling supports the broad scientific consensus.

Pneumococcal vaccine offers protection to HIV infected
A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.

Rotarix effective in severe diarrhea in developing world
Rotavirus is the leading cause of severe, acute gastroenteritis among infants and young children throughout the world and is responsible for an estimated 527,000 deaths among children under five each year.

Promising candidates for malaria vaccine revealed
Walter and Eliza Hall Institute researchers have uncovered a group of proteins that could form the basis of an effective vaccine against malaria.

Vaccine may cure chronic myeloid leukemia CML
Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

Insect cells provide the key to alternative swine flu vaccination
Scientists in Vienna have developed a new technique for producing vaccines for H1N1, 'swine flu', based on insect cells. The research, published today in the Biotechnology Journal, reveals how influenza vaccines can be produced faster than through the traditional method of egg-based production, revealing a new strategy for the fight against influenza pandemics.

H1N1 vaccine clinics open to all, Oklahoma
The Oklahoma City-County Health Department (OCCHD) is offering extended hours and days for both H1N1 and seasonal flu vaccinations at the main building at 921 NE 23rd Street in Oklahoma City.

H1N1 vaccination to include all patients in Pennsylvania, US
Certified healthcare providers who have already immunized patients most at risk of complications from the H1N1 flu virus may now offer the vaccine to anyone who wants it, the Department of Health announced today.

H1N1 Flu Vaccine to all Illinoisans, US
Illinois Department of Public Health Director Dr. Damon T. Arnold announced that beginning Tuesday, December_15, 2009, all Illinoisans will be eligible to receive an H1N1 flu vaccination.

Novartis' Agriflu seasonal influenza vaccine approved in US
The U.S. Food and Drug Administration approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

Novartis inaugurates influenza vaccine manufacturing facility
Novartis inaugurated the US's first ever large-scale flu cell culture vaccine and adjuvant manufacturing facility in Holly Springs, North Carolina.

Safety of pandemic H1N1 vaccines monitored by WHO
WHO estimates that around 80 million doses of pandemic vaccine have been distributed and around 65 million people have been vaccinated. National immunization campaigns began in Australia and the People's Republic of China in late September.

HIV vaccine failure probably caused by adenovirus
The recent failure of an HIV vaccine was probably caused by the immune system reacting to the virus 'shell' used to transmit the therapy around the body, revealed by researchers.

Special polio vaccine drive on children's day, India
The Indian Minister of Health and Family Welfare Shri Ghulam Nabi Azad said that the Indian Government will very soon introduce bi-valent oral polio vaccine to attack the type 1 and type 3 virus to deal with the fresh outbreak of type 3 virus.

H1N1 vaccines to include infants and children
US FDA has approved the use of the CSL Limited's 2009 H1N1 influenza vaccine to include children ages 6 months and older. This vaccine was previously approved only for use in adults, ages 18 years and older.

Many parents, high priority adults didn't get H1N1 vaccine
In US, majority of adults who tried to get the H1N1 vaccine for themselves or their children have been unable to do so, revealed in a poll from Harvard School of Public Health (HSPH).

First annual World Pneumonia Day
Nearly 100 leading global health organizations from around the world joined forces to recognize the first-annual World Pneumonia Day on November 2 and urge governments to take steps to fight pneumonia, the world's leading killer of young children.

H1N1 flu vaccination begins for school children in US
The Centers for Disease Control and Prevention (CDC) reported in the 2009 H1N1 press conference that H1N1 2009 vaccine levels are increasing but are still short of expected levels.

WHO reviewed pandemic vaccine policies and strategies
The Strategic Advisory Group of Experts (SAGE) on Immunization, which advises WHO on policies and strategies for vaccines and immunization, devoted a session of its 27–29 October meeting to pandemic influenza vaccines.

Americans would not take an H1N1 flu vaccine
A new survey hinted that the majority of Americans would not take an H1N1 flu vaccine or drug additive authorized for emergency use by the Food and Drug Administration.

H1N1 vaccine Focetria receives positive opinion from CHMP
Novartis announced that Focetria, the Novartis Influenza A(H1N1) 2009 monovalent vaccine, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA).

Pregnant women should get flu shots
Pregnant women should be sure to get all their flu shots as soon as the vaccines become available this year to protect them against both the seasonal flu and the H1N1 (swine) flu.

New HIV vaccine safe and effective in preventing HIV infection
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand.

H1N1 flu vaccines to be used in 2010 influenza season
Pandemic influenza A H1N1 viruses are becoming much more common than the current seasonal influenza. WHO health experts have recommended that vaccines for use in the 2010 influenza season (southern hemisphere winter) contain the following:

H1N1 flu vaccine donations for developing world
WHO applauds and welcomes the announcement of donations of pandemic H1N1 vaccine made by the United States of America, in concert with Australia, Brazil, France, Italy, New Zealand, Norway, Switzerland, and the United Kingdom.

2009 H1N1 influenza vaccines in healthy adults - early results
There are encouraging reports emerging from various clinical trials of 2009 H1N1 influenza vaccines, conducted by various vaccine manufacturers. Additional companies are expected to announce their preliminary trial results shortly.

H1N1 flu vaccine could control swine flu pandemic
An aggressive vaccination program that first targets children and ultimately reaches 70 percent of the U.S. population would mitigate pandemic influenza H1N1 that is expected this fall, revealed by researchers.

CDC guidelines for seasonal and swine flu vaccines questioned
With the seasonal flu season approaching and uncertainty over whether swine flu will become more severe, new research published by Yale School of Public Health has found that more people are likely to avoid illness if vaccines are given out first to those most likely to transmit viruses, rather than to those at highest risk for complications.

Microneedle patch would replace injections and needles
An array of microneedles could be coated with medicine and act as a painless drug delivery system for flu vaccines, diseases of the eye and more, revealed by researchers.

Swine flu vaccine trials under way, UK
UK's first swine flu vaccine trials, led by the University of Leicester and University Hospitals of Leicester NHS Trust, are taking place at the Leicester Royal Infirmary.

Typhoid vaccine effective in young children
A new study has found that a currently available yet underused vaccine against typhoid fever is highly effective in young children and protects unvaccinated neighbors of vaccinees.

US to launch clinical trials to test 2009 H1N1 influenza vaccine
Scientists in a network of medical research institutions across the United States are set to begin a series of clinical trials to gather critical data about influenza vaccines, including two candidate H1N1 flu vaccines.

Seasonal influenza vaccine for 2009-2010 approved by US
The U.S. Food and Drug Administration announced that it has approved a vaccine for 2009-2010 seasonal influenza in the United States. The seasonal influenza vaccine will not protect against the 2009 H1N1 influenza virus.

Schistosomiasis parasite's Schistosoma mansoni's Genome decoded
Researchers have sequenced the genome of the parasite -- Schistosoma mansoni -- that causes intestinal schistosomiasis (also known as bilharzia or snail fever), a devastating tropical disease that afflicts more than 200 million people in the developing world.

$884 million to purchase H1N1 vaccine, US
U.S. Department of Health & Human Services' Secretary Kathleen Sebelius announced that the health department will commit $884 million to purchase additional supplies of two key ingredients for potential H1N1 vaccine to further prepare the nation for a potential resurgence of the 2009 H1N1 virus.

GSK's cervical cancer vaccine Cervarix got WHO prequalification
The World Health Organization (WHO) has awarded prequalification to Cervarix, GlaxoSmithKline's cervical cancer vaccine. GlaxoSmithKline pharmaceutical company applied for WHO prequalification of Cervarix 2 years ago.

AIDS virus damages gut antibody-producing immune cells
A new research from the NIAID-funded Center for HIV/AIDS Vaccine Immunology suggests that HIV-1 is anything but – moving at breathtaking speed in destroying and dysregulating the body's gut-based B-cell antibody-producing system.

New gene silencing way to turn off cervical cancer genes
Researchers at The University of Queensland have developed a way to deliver drugs which can specifically shut down cancer-causing genes in tumour cells while sparing normal healthy tissues.

Diabetes drug metformin enhances cancer vaccine efficacy
University of Pennsylvania School of Medicine researchers have found that a common anti-diabetic drug might enhance the effectiveness of vaccines. The findings are described this week in an advanced online publication of Nature.

Canada funding H1N1 flu virus research to protect Canadians
The Honourable Leona Aglukkaq, Minister of Health, is pleased to announce another measure to address the H1N1 flu virus. The Government of Canada will fund a national influenza research network focused on pandemic vaccine evaluation.

10 early lessons learned from H1N1 outbreak
A new report - The Pandemic Flu: Lessons from the Frontlines - reviews 10 early lessons learned from the response to the H1N1 (swine) flu outbreak, 10 ongoing core vulnerabilities in U.S. pandemic flu preparedness.

Benefit to women not enough to sway men to get HPV vaccine
Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida State University study.

Immunotherapy with vaccine improves advanced melanoma
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.

Swine flu vaccine candidate prepared by UK
A strain of virus suitable for vaccine manufacture has now been produced and is being made available to the pharmaceutical industry and other flu laboratories.

Gardasil is eligible for UN immunization programs
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck's cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification. GARDASIL is the first cervical cancer vaccine to receive WHO pre-qualification.

AIDS Action observes HIV vaccine awareness day
Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone.

GSK to manufacture A H1N1 influenza vaccine
GSK is committed to supporting governments and health authorities around the world to respond to the emergence of the new A (H1N1) influenza strain.

HIV vaccine by using gene transfer technology
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.

$45 million for infectious disease research, UCI
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded UC Irvine $45 million over five years for infectious disease research.

Gardasil efficacious against HPV 16 infection
In a study of an extended follow up of 290 women naïve to HPV type 16, the HPV 16 component of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] was efficacious against HPV 16 infection for an average of 8.5 years after administration.

Sanofi Pasteur's New Influenza Vaccine Plant, US
Sanofi Pasteur, the vaccines division of sanofi-aventis Group (Euronext: SAN) (NYSE: SNY), announced that the U.S. Food and Drug Administration (FDA) has licensed its new influenza vaccine manufacturing facility.

Infant pain response depends on order of administration of vaccine
Infants who receive the pneumococcal conjugate vaccine (PCV) following the combination vaccine for diphtheria, polio, tetanus, pertussis and Haemophilus influenzae type b (DPTaP-Hib vaccine) appear to experience less pain than those who are immunized in the opposite order, according to a report in the May issue of Archives of Pediatrics & Adolescent Medicine, a theme issue on vaccines.

Universal Influenza vaccine holds promise
An influenza vaccine that protects against death and serious complications from different strains of flu is a little closer to reality, Saint Louis University vaccine researchers have found.

Swine influenza vaccine soon by Lipoxen, UK
Lipoxen plc (AIM:LPX) ("Lipoxen" or "the Company"), a bio-pharmaceutical company specialising in the development of high value differentiated biologicals, vaccines and siRNA delivery, and Cambridge Biostability Ltd (CBL), the developer of temperature stable vaccines and biopharmaceuticals, are pleased to announce that they have achieved positive preclinical results for the delivery of a novel and enhanced influenza vaccine based on the combination of Lipoxen's novel vaccine delivery system ‘ImuXen' and CBL's proprietary VitRIS stabilisation platform.

Australia working on swine flu vaccine
Australian researchers started working hard to develop a vaccine to counter the deadly disease swine influenza.

Potential preventative therapy for Type 1 diabetes
Scientists believe they may have found a preventative therapy for Type 1 diabetes, by making the body's killer immune cells tolerate the insulin-producing cells they would normally attack and destroy, prior to disease onset.

Boosting immune response to destroy tumours
Researchers have discovered how to trigger an improved immune response to cancer that could be included in new clinical trials that use a patient's own cells to destroy tumours.

New tools to study H5N1 vaccines for Bird Flu
An in-depth analysis of blood from patients recovering from the H5N1 avian influenza virus has provided important insights into how to combat the potentially lethal virus.

Prostate cancer vaccine Provenge prolongs survival
Dendreon Corporation (Nasdaq: DNDN) announced that the pivotal Phase 3 IMPACT study of PROVENGE (sipuleucel-T) in men with advanced prostate cancer met its primary endpoint of improving overall survival compared to a placebo control.

Ixiaro to prevent Japanese Encephalitis approved in Europe
Intercell AG (VSE: ICLL) announced that its new vaccine to prevent Japanese Encephalitis, IXIARO, has been approved by the European Commission.

Cervical cancer screening might safely be delayed after HPV vaccine
DNA from human papilloma virus type 16 (HPV16) and HPV type 18 (HPV18) were found in the majority of invasive cervical cancers in New Mexico in the 1980s and 1990s, according to a population-based study published in the March 24 online issue of the Journal of the National Cancer Institute.

New monkey model for HIV
By altering just one gene in HIV-1, scientists have succeeded in infecting pig-tailed macaque monkeys with a human version of the virus that has until now been impossible to study directly in animals.

Human vaccine against bird flu soon
A vaccine to protect humans from a bird flu pandemic is within reach after a new discovery by researchers at the University of Melbourne, Australia.

Meningitis bacteria mimic as human cells to evade immune system
The way in which bacteria that cause bacterial meningitis mimic human cells to evade the body's innate immune system has been revealed by researchers at the University of Oxford and Imperial College London.

Influenza vaccines studies determined by the sponsor
Industry-sponsored studies on influenza vaccines are published in journals with higher rankings (impact factors) and are cited more than studies with other sponsors, but this is not because they are bigger or better, finds a study published on bmj.com today.

Pediatric vaccine prevents pneumococcal meningitis
A standard pediatric vaccine used to prevent several common types of life-threatening infections also effectively reduced the rates of another disease, pneumococcal meningitis, in children and adults, according to a multi-center study led by the University of Pittsburgh School of Medicine.

Gardasil approval delayed for use in women ages 27 - 45
Merck & Co., Inc. announced that the U.S. Food and Drug Administration has issued a second complete response letter regarding the supplemental biologics license application (sBLA) for the use of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] in women ages 27 though 45.

HPV vaccine's hypersensitivity reactions are rare
Hypersensitivity reactions to the quadrivalent HPV vaccine (4vHPV, Gardasil) are uncommon and most schoolgirls can tolerate subsequent doses, finds the first evaluation of the quadrivalent HPV vaccine published on bmj.com.

109 medicines, vaccines in development for HIV AIDS
America's pharmaceutical research companies are testing 109 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Gardasil HPV vaccine prevented genital lesions in men
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.

Gardasil vaccine to prevent cervical cancer in India
MSD Pharmaceuticals India announced the launch of GARDASIL Vaccine, India's first vaccine to help prevent Cervical Cancer caused by the HPV.

2 doses of flu vaccine needed against bird flu pandemic
An international study led by University of Leicester researchers has determined that vaccination will be the best way to protect people in the event of the next influenza pandemic – but that each person would need two doses.

US to bulk purchase BioThrax anthrax vaccine from Emergent BioSolutions
Emergent BioSolutions Inc. (NYSE:EBS) announced that it has signed a new, multi-year, firm fixed price contract with the U.S. Department of Health and Human Services (HHS) to supply an additional 14.5 million doses of BioThrax(R) (Anthrax Vaccine Adsorbed), its FDA licensed anthrax vaccine, for inclusion in the Strategic National Stockpile (SNS).

India to develop HIV AIDS vaccine soon
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced.

HPV vaccine Cervarix in UK's immunisation programme
The UK's leading cervical cancer charity, Jo's Trust, has welcomed the UK's Department of Health's announcement that the HPV vaccine, Cervarix will be used in the national immunisation programme for 12/13 year olds starting in September, 2008.

Travelers' diarrhea vaccine skin patch for travelers
Researchers at The University of Texas School of Public Health have found that patients given a travelers' diarrhea vaccine were significantly less likely to suffer from clinically significant diarrhea than those who received placebo, according to a study published in this week's edition of The Lancet.

Mothers less likely to vaccinate daughters against HPV
U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve mom's acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study.

21% children not fully protected against vaccine-preventable diseases
The U. S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) launched National Infant Immunization Week (NIIW) last week.

New bird flu vaccine may give long-term defense
A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.

GSK's new vaccine Rotarix to prevent gastroenteritis by rotavirus
The U.S. Food and Drug Administration announced the approval of Rotarix, the second oral U.S. licensed vaccine for the prevention of rotavirus, an infection that causes gastroenteritis (vomiting and diarrhea) in infants and children. Rotarix is a liquid and given in a two-dose series to infants from 6 to 24 weeks of age.

Gardasil HPV vaccine reduces abnormal pap test results
A significant drop in abnormal Pap test results happened after girls and women were given Gardasil vaccine to prevent cervical cancer, according to a researcher at the University of Alabama at Birmingham (UAB).

Influenza vaccination for children 6 months through 18 years of age
A panel of immunization experts voted to expand the recommended ages for annual influenza vaccination of children to include all children from 6 months through 18 years of age. The previous recommendation was for vaccination of children from 6 months to 59 months of age.

Drug resistant tuberculosis growing, says WHO
Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to a new report published today. The report presents findings from the largest survey to date on the scale of drug resistance in tuberculosis.

GSK reduces HIV drugs prices for poor countries
GSK today announced significant new price reductions for its HIV medicines offered on a not-for-profit basis to the world's poorest countries. This reduction is the fifth time the company has made a price reduction as part of its pioneering preferential pricing policy originally introduced in 1997.

100 Vaccine articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
7.33